Clinical Trial Update: High Dose Amoxicillin Versus Tetracycline as Second-line Treatment of Resistant Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing high-dose amoxicillin versus tetracycline as second-line therapy for resistant Helicobacter pylori infection has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• tetracycline (tetracycline)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Helicobacter Pylori Treatment Failure | Phase 4 | Status: COMPLETED